Organon (Organon) Growth Rank : 4 (As of Apr. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Growth Rank?

Organon has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Organon's Growth Rank

For the Drug Manufacturers - General subindustry, Organon's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organon's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon's Growth Rank distribution charts can be found below:

* The bar in red indicates where Organon's Growth Rank falls into.

Organon Growth Rank Related Terms

Thank you for viewing the detailed overview of Organon's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (Organon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (NYSE:OGN) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

OGN:Mexico 1OGN:Italy 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Executives

Kirke Weaver	officer: Gen. Counsel & Corp. Secy.	30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302
Ma. Fatima Francisco	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Deborah H Telman	officer: General Counsel	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Kathryn Dimarco	officer: Corporate Controller	30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302
Susanne Fiedler	officer: Chief Commercial Officer	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Vittorio Nisita	officer: Head of Global Business Svcs	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Morrissey Joseph T. Jr.	officer: Head of Manufacturing	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Aaron Falcione	officer: Chief Human Resources Officer	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Deborah R Leone	director	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Martha E Mcgarry	director	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Phillip Ozuah	director	30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302
Geralyn S Ritter	officer: Hd of Ext. Affairs and ESG	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Sandra Milligan	officer: Head of Research & Development	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Cynthia M Patton	director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Alan Ezekowitz	director	C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139